Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index; 4 of the 12 sources its claims cite were checked for support.

Impact of Abrupt Interruption of Home Psychotropic Medications at ICU Admission

Open access
Atherton, Jennifer, Abdrabbo, Maryam, Kassab, Hagar · 2023 · Journal of Pharmacy Technology

Abstract

Background: Abrupt discontinuation of home psychotropic medications is common among critically ill patients but may precipitate clinically significant withdrawal. Objective: To determine the percent of patients with interruptions in home psychotropic medications upon intensive care unit (ICU) admission and to identify outcomes associated with these interruptions. Methods: This was an institutional review board-approved, single-center, retrospective study of critically ill patients with a history of mental illness taking an antipsychotic or antidepressant medication. The primary outcome was the percent of patients with interruption in at least one home psychotropic medication for ≥24 hours upon ICU admission. Secondary outcomes included time to psychotropic re-initiation, percent of home psychotropic medications restarted in the ICU, ICU length of stay (LOS), delirium, withdrawal-related complications, need for acute antipsychotics or benzodiazepines, and reasons for psychotropic interruption. Results: Among 183 patients, 93 (50.8%) had interruptions in home psychotropic therapy for ≥24 hours upon ICU admission. Mean time to reinitiation of at least one psychotropic agent was 1.4 days, and 16.4% of patients did not have any home psychotropics restarted. Patients with psychotropic interruption had a longer ICU LOS ( P = 0.01) and greater incidence of ICU delirium ( P < 0.01). Withdrawal-related complications were similar between groups. Acute antipsychotic use was greater in patients with psychotropic interruption ( P < 0.01). Acute benzodiazepine use was not different between groups ( P = 0.87). Most patients did not have a documented reason for therapy interruption. Conclusion and Relevance: Unless contraindicated, clinicians should attempt to restart home psychotropic medications as soon as possible in critically ill patients.

Overview

CoChat Summary

TL;DR

In this single-center retrospective study of 183 critically ill patients with preadmission psychotropic medications, 50.8% had at least one home psychotropic interrupted for ≥24 hours after ICU admission. Interruption was associated with longer ICU length of stay, more ICU delirium, and greater PRN antipsychotic use, while most interruptions had no documented reason.

Key findings

  • Among 183 patients, 93 (50.8%) had interruption in at least one home psychotropic medication for ≥24 hours upon ICU admission.
  • Patients with interruption had longer ICU LOS (4.0 vs 2.9 days; P = 0.01), greater incidence of positive CAM-ICU delirium (20.4% vs 3.3%; P < 0.01), and more PRN antipsychotic use (15.1% vs 3.3%; P < 0.01); PRN benzodiazepine use did not differ (25.8% vs 24.4%; P = 0.87).
  • Among patients with interruption, 42 (45.2%) had all home psychiatric medications restarted, 17 (18.3%) had at least half restarted, 3 (3.2%) had less than half restarted, and 31 (33.3%) had none restarted; mean time to reinitiation of at least one psychotropic was 2.6 ± 1.2 days in Results/Table 2, while the Abstract reports 1.4 days.
  • Most patients with interruption had no documented reason for discontinuation (67.7%); documented reasons included inability to administer dosage form (12.9%), adverse drug reaction or drug interaction (8.6%), and patient refusal (6.5%).

Methods

  • Institutional review board-approved, single-center, retrospective study of patients admitted to any ICU between January 2019 and June 2021. Inclusion required age ≥18 years, ICU admission ≥24 hours, documented history of mental health disorder, and preadmission antipsychotic or antidepressant medication; exclusions included long-acting injectable antipsychotic, home psychotropic overdose, COVID-19, substance use disorder, traumatic brain injury, or seizure disorder.
  • Primary outcome was percent of patients with interruption in at least one home psychotropic medication for ≥24 hours upon ICU admission. Secondary outcomes included time to reinitiation, percent of home psychotropics restarted, ICU LOS, delirium, withdrawal-related complications, need for acute antipsychotics or benzodiazepines, and reasons for interruption.
  • Data were extracted from the electronic medical record. Analysis used descriptive statistics, Fisher exact test for categorical data, and two-tailed independent t-test for continuous data; statistical significance was defined as P ≤ 0.05.

Limitations

  • The paper states it was retrospective, conducted at a single health system, and had a relatively small sample size; chart review may not have captured all withdrawal-related complications due to lack of documentation, and other medical causes could have contributed to withdrawal-type symptoms.
  • The paper states there was no way to assess accuracy of preadmission medication reconciliations, including possible noncompliance or uncaptured psychotropic medications; ICU LOS may have been affected by confounding factors, including greater medical ICU admission and possibly higher severity of illness in the interruption group.
  • Evident from the text: the Abstract reports mean time to reinitiation as 1.4 days, whereas Results/Table 2 report 2.6 ± 1.2 days; the study also did not use multivariable adjustment for confounders.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1177/87551225231182286

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

4 Valid · 0 Not valid · 4 Not checked · 37 Own results and interpretations

23 more claims

Create a free account to see all 45 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 9
  • Probably not a substantial claim. 9

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 16 references

Research works printed but not linked: 1

  1. Warner CH, 2006, Am Fam Physician, 74, 449

Cited by

See all 6

Metadata

Authors
Atherton, J., Abdrabbo, M., & Kassab, H.
Affiliations
  • St. Joseph’s University Medical Center (US)
  • Yale New Haven Hospital (US)
Corresponding author
Atherton, Jennifer
Venue
Journal of Pharmacy Technology
Published
2023-06-30
Volume
39
Issue
4
Pages
199-204
ISSN
  • 1549-4810 (ISSN-L)
  • 8755-1225
OpenAlex
W4382679913
Cited by
6
References
16
Citations by year
2026: 2 · 2025: 1 · 2024: 3
FWCI
1.24
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Pharmacy Technology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
Keywords
drug discontinuation, intensive care unit admission, critical illness, antipsychotic drugs, antidepressants, withdrawal symptoms, delirium, ICU length of stay, benzodiazepines, mental illness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of Abrupt Interruption of Home Psychotropic Medications at ICU Admission. https://app.cochat.ai/papers/10.1177/87551225231182286
The paper
Atherton, J., Abdrabbo, M., & Kassab, H. (2023). Impact of Abrupt Interruption of Home Psychotropic Medications at ICU Admission. Journal of Pharmacy Technology. https://doi.org/10.1177/87551225231182286

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.